Search Results

Displaying Results 2676-2700 of 12234 "'L'"

Mar 27, 2026, 12:47 ET A Knight Therapeutics Inc. se classifica na Segunda edição do ranking anual Canada's Top Growing Women-Led Companies e na sétima edição do ranking anual Women Lead Here do The Globe and Mail, que destacam a diversidade de gênero entre os executivos

ng-anual-canadas-top-growing-womenled-companies-e-na-setima-edicao-do-ranking-anual-women-lead-here-do-the-globe-and-mail-que-destacam-a-diversidade-de-genero-e-302727448.htmlFONTE Knight Therapeutics Inc.

More news about: Knight Therapeutics Inc.


Mar 27, 2026, 11:31 ET Gradient Toxicologist Lindsey Borton Receives Society of Toxicology Award

the journal, Alternatives to Animal Experimentation (ALTEX). Read the published paper in ALTEX: Borton, L; Coleman, K. 2025. "Material-mediated pyrogens in medical devices: Myth or reality?" ALTEX – Altern. Anim. Ex.

More news about: Gradient LLC


Mar 27, 2026, 10:44 ET Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting

gel for 16 weeks in patients with acneKircik L, et alPoster # 73022

More news about: Sun Pharma


Mar 27, 2026, 10:00 ET Steel Dynamics Thanks Richard P. Teets, Jr. and Gabriel L. Shaheen for their Exemplary Board Service

March 27, 2026 /PRNewswire/ -- Steel Dynamics, Inc. (NASDAQ/GS: STLD) announced that Richard P. Teets, Jr. and Gabriel L. Shaheen will be retiring from the Steel Dynamics Board of Directors effective as of the Company's 2026 Annual Meeting of Shareholders taking place on

More news about: Steel Dynamics, Inc.


Mar 27, 2026, 10:00 ET Grant & Eisenhofer P.A. Announce a Summary Notice of Pendency and Proposed Settlement For All Current Stockholders of Hertz Global Holdings, Inc. ("Hertz") Stock and All Persons or Entities Who or Which Held Shares of Hertz Global Holdings, Inc. Stock Anytime Between and Including November 10, 2021 and February 9, 2023

it will resolve all claims in the Action.A settlement hearing will be held on June 3, 2026 at 1:30 p.m. at the Court of Chancery in the Leonard L. Williams Justice Center, 500 North King Street, Wilmington, DE 19801, to determine, among other things, (i) whether the proposed Settlement on the terms

More news about: Grant & Eisenhofer P.A.


Mar 27, 2026, 10:00 ET AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

PMC5731650.Song EJ, Ehst B, Glick B, Lewitt GM, Rich P, Ezra N, Bagel J, Anschutz T, Bialik B, Duan C, Ashley D, Patel M, St John G, Setty AR, Ackerman L. Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16. Dermatol Ther (Heidelb).

More news about: AbbVie


Mar 27, 2026, 09:48 ET ADAMA Reports Fourth Quarter and Full Year 2025 Results

6.7 %USD L 3M3.65 %

More news about: ADAMA Ltd.


Mar 27, 2026, 09:46 ET LifeQuotes.com Reveals Best Life Insurance Rates for Multiple Sclerosis (MS) Patients - Our Top Picks for 2026

residual impairment, age 66, history of hypertension, was able to buy a $15,000 Whole Life policy for $1,268 per year.Tyler L. of Spring, TX, MS patient with no attacks in the last 10 years, age 45, was able to buy a $1 million policy for $3,035 per year.Zieba offered

More news about: Life Quotes, Inc.


Mar 27, 2026, 09:00 ET UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa

System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017;177(5):1401–09.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Kimball AB, Jemec GBE, Yang M, et al. Assessing the validity, responsiveness

More news about: UCB


Mar 27, 2026, 08:39 ET Dizal's ZEGFROVY® (Sunvozertinib) Shows Profound Antitumor Activity as First-Line Treatment in Advanced NSCLC Patients with PACC or Other Uncommon Mutations at ELCC 2026

studies have shown that patients with these mutations exhibit poorer prognosis than those with classical EGFR common mutations (exon 19 deletions and L858R), underscoring a significant unmet medical need for effective, well-tolerated therapies with broader activity cross the EGFR mutation spectrum.ZEGFROVY,

More news about: Dizal


Mar 27, 2026, 07:10 ET OceanaGold Files Annual Information Form and Updated Technical Reports for Haile, Macraes and Didipio

B. Drury, Underground Engineering Superintendent, J. Moore, Group Head of Resource Development, D. Corley, Principal Resource Development Geologist, L. Standridge (Call & Nicholas Principal Engineer, Geotechnical), R. Cook (Call & Nicholas Principal Engineer, Geological), J.N. Janney-Moore (NewFields

More news about: OceanaGold Corporation


Mar 27, 2026, 06:59 ET Satellite Propellant Tanks Market worth $1.27 billion by 2032 - Exclusive Report by MarketsandMarkets™

manufacturers to develop tanks that support efficient fuel use, long-term storage, and consistent propulsion performance.By Capacity, the 5-50 L segment is expected to record the highest CAGR of 10.6% between 2026 and 2032.By Architecture, High-pressure vessels are expected to be the fastest-growing

More news about: MarketsandMarkets


Mar 27, 2026, 06:45 ET Neutrogena®, Aveeno® and Rogaine® Release New Dermatology Research and Clinical Skincare Innovations on Healthy Aging, Moisturization, Sun Protection and Acne

Parsa R, Rank L, et al. Dual-Action Antioxidant Serum for Ultraviolet-Induced Skin Protection Compared with Placebo. Presented at: American Academy of Dermatology Annual Meeting; March 27-31, 2026; Denver, Colorado.iv Lain E, Zaleski E, Shyr T, Adenaike A, Rossi L, Miller D. Supporting

More news about: Kenvue Inc.


Mar 27, 2026, 05:20 ET The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB

for strategy, governance, and delivery across both product and production. Previously, Linda was Global Managing Director for Womenswear, with full P&L responsibility for a business area generating 40 billion SEK in revenue. She has extensive experience in strategic and transformational work, as well

More news about: BioArctic


Mar 27, 2026, 05:13 ET Hainan Daily Press Group, Malaysia's Nanyang Siang Pau Jointly Release ASEAN Investment Survey as Hainan FTP Marks 100 Days of Special Customs Operations

browser: https://www.hicn.cn/page?n=2810678&m=1&s=1044&l=1021.Photo - https://mma.prnewswire.com/media/2944042/image1.jpg

More news about: Hainan International Media Center (HIMC)


Mar 27, 2026, 05:12 ET The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB

for strategy, governance, and delivery across both product and production. Previously, Linda was Global Managing Director for Womenswear, with full P&L responsibility for a business area generating 40 billion SEK in revenue. She has extensive experience in strategic and transformational work, as well

More news about: BioArctic


Mar 27, 2026, 00:40 ET Neapco Holdings LLC ogłasza oficjalne zakończenie przejęcia Grupy IFA, tworząc globalnego lidera w dziedzinie rozwiązań układów napędowych

„Dzisiejszy dzień to znaczący kamień milowy dla Neapco i IFA" – powiedział Kenneth L. Hopkins, President i Chief Executive Officer Neapco. „Łącząc nasze możliwości, talent i wspólne zaangażowanie w doskonałość inżynieryjną, tworzymy silniejszą,

More news about: Neapco Holdings, LLC


Mar 27, 2026, 00:24 ET Neapco Holdings LLC gibt offiziellen Abschluss der Übernahme der IFA Group bekannt und schafft einen globalen Anbieter führender Antriebslösungen

„Heute ist ein bedeutender Meilenstein für Neapco und IFA", sagte Kenneth L. Hopkins, Präsident und Chief Executive Officer von Neapco. „Indem wir unsere Fähigkeiten, unsere Talente und unser gemeinsames Engagement für technische

More news about: Neapco Holdings, LLC


Mar 27, 2026, 00:10 ET Neapco Holdings LLC Announces the Official Close of IFA Group Acquisition, Creating a Global Leader in Driveline Solutions

"Today marks a significant milestone for Neapco and IFA," said Kenneth L. Hopkins, President and Chief Executive Officer, Neapco. "By combining our capabilities, talent, and shared commitment to engineering excellence, we are

More news about: Neapco Holdings, LLC


Mar 26, 2026, 23:54 ET Akeso Reports Full-Year 2025 Financial Results

including:Ivonescimab: 1L PD-L1(+) NSCLCCadonilimab: 1L gastric cancer and 1L cervical cancerOther products: Multiple indications for penpulimab, ebdarokimab and ebronucimabWith stable pricing for core first-line (1L) indications and improved hospital access,

More news about: Akeso, Inc.


Mar 26, 2026, 23:54 ET Neapco Holdings LLC Announces the Official Close of IFA Group Acquisition, Creating a Global Leader in Driveline Solutions

"Today marks a significant milestone for Neapco and IFA," said Kenneth L. Hopkins, President and Chief Executive Officer, Neapco. "By combining our capabilities, talent, and shared commitment to engineering excellence, we are

More news about: Neapco Holdings, LLC


Mar 26, 2026, 22:02 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of On Holding AG - ONON

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Mar 26, 2026, 22:02 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ePlus, inc. - PLUS

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Mar 26, 2026, 22:02 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz

More news about: Pomerantz LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.